"From the Bedside to the Laboratory and Back Again" was the topic of a presentation by Dr. Eugene A. Woltering for the Carcinoid Cancer Foundation's Symposium, "Neuroendocrine Tumor Management: The Era of Personalized Medicine," held on May 1, 2011 at Mt. Sinai Medical Center in New York City.

Following his presentation, "From the Bedside to the Laboratory and Back Again," for the Carcinoid Cancer Foundation's May 2011 Symposium, "Neuroendocrine Tumor Management: The Era of Personalized Medicine," Dr. Eugene Woltering answered questions from the audience.  Includes the "Parable of the Yellow Corvette", Sandostatin questions, Black Raspberry Powder questions, when to do scans and tests and more.

Dr. Edward Wolin, Co-Director of the Cedars-Sinai Carcinoid and Neuroendocrine Tumor Program in Los Angeles, was a guest speaker for the Carcinoid Cancer Foundation's May 1, 2011 Symposium, Neuroendocrine Tumor Management: The Era of Personalized Medicine. Dr. Wolin spoke about "Carcinoid and NETs in 2011: Now, New, Next" including emerging techniques for finding NET tumors, new scans being developed, more effective treatments that replace the "Wait & See" approach of old and more.  Great view of  what works and when for NETs!

"Surgery for Neuroendocrine Tumors: What Every Patient Should Know" is the topic of the presentation by Dr. Rodney Pommier, Professor of Surgery, Division of Surgical Oncology, Oregon Health & Science University. This video is made possible through a collaborative effort of the New Jersey Carcinoid Cancer Network and the Carcinoid Cancer Foundation. For further information, please contact: New Jersey Carcinoid Cancer Network, http://www.njcarcinoidnetwork.org, 201-891-2259 or 609-812-9294; Carcinoid Cancer Foundation, http://www.carcinoid.org, 888-722-3132

Imagine a treatment created just for you as a carcinoid or other neuroendocrine tumor patient based upon a personalized genomic analysis. This is the cutting-edge research which is the focus of the work of Michael J. Demeure, MD, and his team at TGen, the Translational Genomics Research Institute in Arizona. Dr. Demeure was the guest speaker for the Carcinoid Cancer Foundation's April 2010 symposium at Mt. Sinai Medical Center in New York City.

Carcinoid Cancer Foundation Presents Eugene Woltering, MD, FACS

What prompted carcinoid and neuroendocrine tumor specialist Dr. Eugene Woltering to become interested in these rare cancers? Listen to Dr. Woltering, currently Section Chief of Surgical Oncology and Endocrine Surgery; The James D. Rives Professor of Surgery and Neuroscience; and Director of Surgical Research at LSU Health Sciences Center in Kenner, Louisiana, talk about his days as a medical student at Ohio State and how that led to his passion as a physician.